{"id":"W2472707660","doi":"10.1038/bjc.2016.185","title":"Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancer","year":2016,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":true,"ca_institutions":"Royal Victoria Regional Health Centre","funders":"Celgene","keywords":"Gemcitabine; Medicine; Internal medicine; Capecitabine; Oncology; Pancreatic cancer; Regimen; Cancer; Gastroenterology; Performance status; Fluorouracil; Neutropenia; Chemotherapy; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005262905,0.0003056816,0.001271439,0.0001949271,0.0000887783,0.00005016991,0.0001844748,0.0001151622,0.01197839],"category_scores_gemma":[0.0003175083,0.0001744678,0.0002432823,0.0002353146,0.0002824319,0.0003568392,0.00003409869,0.000303689,0.00001034732],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005476907,"about_ca_system_score_gemma":0.001488642,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002045733,"about_ca_topic_score_gemma":0.001889437,"domain_scores_codex":[0.9972469,0.0001173713,0.0008659892,0.0003346882,0.0007628748,0.0006721301],"domain_scores_gemma":[0.9968765,0.0004430736,0.000449828,0.000249746,0.001551826,0.0004289729],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.07838471,0.001025606,0.696924,0.0006848003,0.003295571,0.001658129,0.0003519392,0.000003147729,0.0004369685,0.000006864705,0.00717967,0.2100486],"study_design_scores_gemma":[0.04710955,0.006051878,0.9023641,0.004372689,0.001312611,0.0007561927,0.00006365639,0.00003428036,0.0002576289,0.0001625778,0.03711314,0.0004016936],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9698718,0.02494104,0.0009904401,0.001849856,0.0002853725,0.001291456,0.0006369165,0.00001602508,0.0001171],"genre_scores_gemma":[0.9653013,0.01468158,0.003722401,0.001560447,0.0008304741,0.001262031,0.0000100011,0.00009643136,0.01253529],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2096469,"threshold_uncertainty_score":0.9889248,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02635132856975869,"score_gpt":0.3404186780141752,"score_spread":0.3140673494444165,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}